The role of adipocytokines on depressive symptoms of patients with chronic kidney disease

References

• Zalai D, Szeifert L, Novak M. Psychological distress and depression in patients with chronic kidney disease. Semin Dial 2012;25:428–438
   Web of Science ®Google Scholar
• Yu ZL, Yeoh LY, Seow YY, Luo XC, Griva K. Evaluation of adherence and depression among patients on peritoneal dialysis. Singapore Med J 2012;53:474–480
   Google Scholar
• Tsai YC, Chiu YW, Hung CC, et al. Association of symptoms of depression with progression of chronic kidney disease. Am J Kidney Dis 2012;60:54–61
   PubMed Web of Science ®Google Scholar
• Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004;50:1511–1525
   PubMed Web of Science ®Google Scholar
• Jeguier E. Leptin signaling, adiposity, and energy balance. Ann NY Acad Sci 2002;967:379–388
   Google Scholar
• Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating Ghrelin levels are decreased in human obesity. Diabetes 2001;50:707–709
   PubMed Web of Science ®Google Scholar
• Nguyen AD, Mitchell NF, Lin S, et al. Y1 and Y5 receptors are both required fort he regulation of food intake and energy homeostasis in mice. PLoS One 2012;7. [Epub ahead of print]
   Google Scholar
• Falcao-Pires I, Castro-Chaves P, Miranda- Silva D, Lourenço AP, Leite-Moreira AF. Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today 2012;17:880–889
   PubMed Web of Science ®Google Scholar
• Smitka K, Papezova H, Vondra K, Hill M, Hainer V, Nedvidkova J. A higher response of plasma neuropeptide Y, growth hormone, leptin levels and extracellular glycerol levels in subcutaneous abdominal adipose tissue to Acipimox during exercise in patients with bulimia nervosa: single-blind, randomized, microdialysis study. Nutr Metab (Lond) 2011;8:81
   Google Scholar
• Harvey J. Leptin: a diverse regulator of neuronal function. J Neurochem 2007;100:307–313
   Google Scholar
• Lu XY, Kim CS, Frazer A, Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 2006;103:1593–1598
   PubMed Web of Science ®Google Scholar
• Yamada N, Katsuura G, Ochi Y, et al. Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 2011;152:2634–2643
   PubMed Web of Science ®Google Scholar
• Mickey BJ, Zhou Z, Heitzeg MM, et al. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry 2011;68:158–166
   PubMed Web of Science ®Google Scholar
• Domschke K, Dannlowski U, Hohoff C, et al. Neuropeptide T (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 2010;20:301–309
   PubMed Web of Science ®Google Scholar
• Cizza G, Nguyen VT, POWER study group, et al. Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the premenopausal, osteopenia/osteoporosis, women, alendronate, depression (POWER) study. J Clin Psychiatry 2010;71:1079–1087
   PubMedGoogle Scholar
• Lehto SM, Houtari A, Niskanen L, et al. Serum adiponectin and resistin levles in major depressive disorder. Acta psychiatr Scand 2010;121:209–215
   PubMed Web of Science ®Google Scholar
• Steiger A, Dresler M, Schüssler P, Kluge M. Ghrelin in mental health, sleep, memory. Mol Cell Endocrinol 2011;340:88–96
   Google Scholar
• Mar RH, Cheung WW. Is ghrelin a biomarker for mortality in end-stage renal disease? Kidney Int 2011;79:697–699
   Google Scholar
• Testa A, Mallamaci F, Macri R, et al. Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients. J Hypertens 2010;28:1745–1751
   Google Scholar
• Kawamura R, Doi Y, Osawa H, et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant 2010;25:3236–3240
   Google Scholar
• Kir HM, Eraldemir C, Dervisoglu E, Caglayan C, Kalender B. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein. Clin Lab 2012;58:495–500
   PubMed Web of Science ®Google Scholar
• Daugirdas JT. Second generation logarithmic estimates of single pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205–1213
   PubMed Web of Science ®Google Scholar
• Lightfoot BO, Caruana RJ, Mulloy LL, Fincher ME. Simple formula for calculating normalized protein catabolic rate (nPCR) in hemodialysis (HD) patients (abstract). J Am Soc Nephrol 1993;4:363
   Google Scholar
• Tzamaloukas AH, Murata GH, Malhotra D, Sena P, Patron A. Urea kinetic modeling in continuous peritoneal dialysis patients. Effect of body composition on the methods for estimating urea volume of distribution. ASAIO J 1993;39:M359–M362
   Google Scholar
• Keshaviah PR, Nolph KD. Protein catabolic rate calculations in CAPD patients. ASAIO Trans 1991;37:M400–M402
   Google Scholar
• Van Acker BA, Koomen GC, Kopman MG, de Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992;340:1326–1329
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Grene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461–470
   PubMed Web of Science ®Google Scholar
• Dombros N, Dratwa M, Feriani M, et al. European Best Practice Guidelines for peritoneal dialysis. The initiation of dialysis. Nephrol Dial Transplant 2005;20:3–7
   Google Scholar
• Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 1985;27:58–65
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I), Clinical Version. Washington, DC: American Psychiatric Press, Inc; 1997
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed., Washington, DC: Author;1996
   Google Scholar
• Corapcıoglu A, Aydemir O, Yıldız M, Esen A, Koroglu E. DSM-IV Eksen I Bozuklukları (SCID-I) için yapılandırılmış, Klinik Görüşme, klinik versiyon. Ankara: Hekimler Yayın Birliği; 1999
   Google Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–571
   PubMed Web of Science ®Google Scholar
• Beck AT, Epstein N, Brown G, Ster RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893–897
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13:595–605
   PubMed Web of Science ®Google Scholar
• Hisli-Sahin N, Durak A. Kısa Semptom Envanteri; Türk Gençleri için uyarlaması. Türk Psikoloji Dergisi 1994;9:44–56
   Google Scholar
• Ulusoy M, Sahin N, Erkman H. Turkish version of the Beck Anxiety Inventory: psychometric properties. J Cogn Psychother Int Quaterly 1998;12:28–35
   Google Scholar
• Jain N, Trivedi MH, Rush AJ, et al. Rationale and design of the chronic kidney disease antidepressant sertraline trial (CAST). Contemp Clin Trials 2013;34:136–144
   Google Scholar
• Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL. Screening, diagnosis and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol 2007;2:1332–1342
   PubMed Web of Science ®Google Scholar
• Peng T, Hu Z, Guo L, Xia Q, Li D, Yang X. Relationship between psychiatric disorders and quality of life in nondialysis patients with chronic kidney disease. Am J Med Sci 2013;345:218–221
   PubMed Web of Science ®Google Scholar
• Novakovic M. Anxiety disorders in dialysis patients. Med Pregl 2007;60:484–488
   Google Scholar
• Gillanders S, Wild M, Deighan C, Gillanders D. Emotion regulation, affect, psychosocial functioning and well-being in hemodialysis patients. Am J Kidney Dis 2008; 51:651–662
   Google Scholar
• Gamondi C, Gali N, Schonholzer C, et al. Frequency and severity of pain and symptom distress among patients with chronic kidney disease receiving dialysis. Swiss Med Wkly 2013;22:143 . [Epub ahead of print]
   Google Scholar
• Son YJ, Choi KS, Park YR, Bae JS, Lee JB. Depression, symptoms and the quality of life in patients on hemodialysis for end-stage renal disease. Am J Nephrol 2009;29:36–42
   Google Scholar
• Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr 2007;17:381–388
   PubMed Web of Science ®Google Scholar
• Schellekens H, Finger BC, Dinan TG, Cryan JF. Ghrelin signalling and obesity: at the interface of stres, mood and food reward. Pharmacol Ther 2012;135:316–326
   PubMed Web of Science ®Google Scholar
• Lehto SM, Huotari A, Niskanen L, et al. Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatr Scand 2010;121:209–215
   PubMed Web of Science ®Google Scholar